PepVial score history

Score over time

Every entry newest first

1. November 5, 2026Raised from1.89→to1.92(+0.03)

   Pricing re-checked on 5 November 2026 after the market medians were recalculated with Peptyes added pricing 5.7 to 5.9.

2. November 2, 2026Lowered from1.90→to1.89(-0.01)

   Market medians updated after Pacific Edge Labs was added pricing 5.8 to 5.7.

3. November 2, 2026Lowered from1.96→to1.90(-0.06)

   Market medians updated after Snowman Research was added pricing 6.2 to 5.8.

4. November 1, 2026Raised from1.90→to1.96(+0.06)

   Market medians updated after Bluum Peptides was added pricing 5.8 to 6.2.

5. October 29, 2026Lowered from1.96→to1.90(-0.06)

   Market medians updated after Delix Labs and Ageless Peptides were added pricing 6.2 to 5.8.

6. October 27, 2026Lowered from1.98→to1.96(-0.02)

   Market medians updated after S1Research was added pricing 6.3 to 6.2.

7. October 27, 2026Raised from1.96→to1.98(+0.02)

   Pricing recomputed on 27 October 2026: listings added for a newly reviewed vendor (Peptide Pro) moved the market median for the same products pricing 6.2 to 6.3.

8. October 26, 2026Lowered from1.98→to1.96(-0.02)

   Pricing recomputed on 26 October 2026: listings added for a newly reviewed vendor (StudzPeptides) moved the market median for the same products: pricing 6.3 to 6.2.

9. October 26, 2026Raised from1.96→to1.98(+0.02)

   Pricing recomputed on 26 October 2026: a vendor was removed from the directory, which moved the market median for the same products: pricing 6.2 to 6.3.

10. October 24, 2026Raised from1.95→to1.96(+0.01)

    Prices and certificates re-read on 24 October 2026 in the owner's signed-in browser; other vendors move only through the market medians: pricing 6.1 to 6.2.

11. October 23, 2026Lowered from1.96→to1.95(-0.01)

    Pricing recomputed on 23 October 2026 under the revised rule E1 (standing offers), which prices a size at the lowest total a buyer can pay without a code under standing prices, so a standing offer that includes a second vial at no extra cost now counts at all the milligrams received, in the vendor's own price and in the market medians for the same products: pricing 6.2 to 6.1.

12. October 23, 2026Lowered from1.98→to1.96(-0.02)

    Pricing recomputed on 23 October 2026 from current listings with the published rule (section E), after listings added or updated since 22 October, including a newly reviewed vendor's, moved the market median for the same products: pricing 6.3 to 6.2.

13. October 22, 2026Re-checked, no change (1.98)

    Re-scored on 22 October 2026 under version 2 of our published rules. No score change. The testing gate is now computed from the certificates instead of set by hand: 0 of 5 products have a certificate from a directory laboratory with the key confirmed at the laboratory, fewer than the half required, so the testing cap applies; the cap sits above the weighted score, so it does not lower it.

14. October 22, 2026Raised from1.85→to1.98(+0.13)

    Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. shipping and refunds 5.0 to 4.5, pricing 4.0 to 6.3, operating history 2.0 to 1.6, transparency 3.0 to 1.0.

15. October 21, 2026Lowered from2.13→to1.85(-0.28)

    Lab 0.5 to 0. No product we list has a certificate, and under our published rule the lab score is zero rather than a small floor.

16. October 14, 2026First publishedat2.13

    lab 0.5 / shipping 5.0 / pricing 4.0 / tenure 2.0 / transparency 3.0. Testing gate not met: nothing published to verify.